Plain-English translation of NCT06778746 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Asthma research guide →This study looks at medical records from people with severe asthma who have been treated with biologic medications—newer drugs that work differently than traditional asthma medicines. Researchers want to learn more about which patients benefit most from these treatments, how long people stay on them, and whether they help control asthma symptoms. The study covers patients treated in Hong Kong since 2003.
Severe asthma can be difficult to control with standard medications, and biologic treatments offer hope for some patients. However, doctors need real-world information about how well this medication works for different people, who should receive it, and what happens over time—information that can only come from reviewing actual patient experiences.
You likely qualify if…
You likely don't qualify if…
You won't need to do anything active—researchers will simply review your existing medical records from your hospital or clinic. They will collect information about which biologic medication you took, when you started and stopped it, your asthma symptoms, blood tests, and any other health conditions you may have. Your name and personal details will be kept confidential and replaced with a code number.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
Hong Kong
Enrollment target
~360 participants
Started
December 2024
Primary completion
December 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in March 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Fanny WS Ko, MD
Chinese University of Hong Kong
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.